THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ONWARD MEDICAL BV EO -,12 63E NL0015000HT4 BAW/UFN
© 2024 Xetra Newsboard
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,020 | 4,230 | 08:34 | |
| 4,020 | 4,060 | 08:19 |
XFRA 63E: AUSSETZUNG/SUSPENSION
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ONWARD MEDICAL BV EO -,12 63E NL0015000HT4 BAW/UFN
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | ONWARD Medical NV: ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights | Received FDA authorization and recorded first commercial sales of ARC-EX System
Secured strategic investment from Ottobock and extended cash runway for two years
Gained exclusive rights to premier... ► Artikel lesen | |
| 26.03. | ONWARD Medical NV: ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility | The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study
The Company is building a portfolio of purpose-designed leads to optimize delivery... ► Artikel lesen | |
| 19.03. | ONWARD Medical NV: ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast | EINDHOVEN, the Netherlands, March 19, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement... ► Artikel lesen | |
| 04.03. | ONWARD Medical NV: ONWARD Medical to Advance Parkinson's Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense | The Michael J. Fox Foundation for Parkinson's Research is supporting a study addressing mobility challenges in Parkinson's disease; the first participant was enrolled in late 2024
A US Department... ► Artikel lesen | |
| 25.02. | ONWARD Medical NV: ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy | Study shows significant functional improvements after one year of ARC-EX Therapy
Improvements were observed throughout one-year treatment period with no plateau
Results demonstrate the importance... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
